The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy

OBJECTIVE: To assess whether neuropathy with anti-myelin-associated glycoprotein (MAG) antibody may improve after treatment with ibrutinib, an oral inhibitor of Bruton tyrosine kinase, we prospectively treated with ibrutinib a cohort of 3 patients with anti-MAG neuropathy and Waldenström macroglobul...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neurol Neuroimmunol Neuroinflamm
Hoofdauteurs: Castellani, Francesca, Visentin, Andrea, Campagnolo, Marta, Salvalaggio, Alessandro, Cacciavillani, Mario, Candiotto, Cinzia, Bertorelle, Roberta, Trentin, Livio, Briani, Chiara
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7176252/
https://ncbi.nlm.nih.gov/pubmed/32284437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000720
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items